ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Dispute At City of Hope Pits Center Against For-Profit Physician Group.

May 28, 2010

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

April 21, 1995

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014